07 Jan 2001

Carvomin® Magentropfen (Carvomin® Magentropfen mit Pomeranze Lösung) - Deutschland

Updated: 07 Jan 2001

Carvomin® Magentropfen mit Pomeranze

Dyspeptische Beschwerden wie Völlegefühl, Blähungen, Aufstoßen.

Carvomin® Magentropfen Description, Presentation and Dosage

Carvomin® Magentropfen Description

Carvomin® Magentropfen Drug Class Description


Carvomin® Magentropfen Drug Description

100 g enth.: Pomeranzenschalentinktur (DAB) 80 g.

Carvomin® Magentropfen Generic Name

Carvomin® Magentropfen mit Pomeranze Lösung

Carvomin® Magentropfen Presentation

Carvomin® Magentropfen Presentation

Carvomin® Magentropfen mit Pomeranze

Carvomin® Magentropfen Manufacturer


Related Learning Zones

Bedwetting Knowledge Centre and CME

Bedwetting Knowledge Centre and CME

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and a CME activity ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Carvomin® Magentropfen Dosage

Carvomin® Magentropfen Adult Dosage


Carvomin® Magentropfen Precautions, Reactions and Contraindications

Carvomin® Magentropfen Special Precautions

Related Drugs - Gastroenterology

Back to top